• 1. Achieving high thermal stability of different rare-earth ions in a single matrix host via the manipulation of the local structure by a solid solution?
  Xiuxia Yang,Lei Zhao,Zhichao Liu,Shuyu Tian,Hao Zhang,Xuhui Xu,Jianbei Qiu,Xue Yu Phys. Chem. Chem. Phys., 2020,22, 16294-16300
• 2. Agricultural livelihoods in coastal Bangladesh under climate and environmental change – a model framework?
  Attila N. Lázár,Derek Clarke,Helen Adams,Abdur Razzaque Akanda,Sylvia Szabo,Robert J. Nicholls,Zoe Matthews,Dilruba Begum,Abul Fazal M. Saleh,Md. Anwarul Abedin,Andres Payo,Peter Kim Streatfield,Craig Hutton,M. Shahjahan Mondal,Abu Zofar Md. Moslehuddin Environ. Sci.: Processes Impacts, 2015,17, 1018-1031
• 3. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 4. An automated in-chip-catalytic–spectrophotometric method for determination of copper(ii) using a multisyringe flow injection analysis-multipumping flow system?
  Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504
• 5. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans Benzofurans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans

Recent Advances in the Study of 2-Ethyl-1-benzofuran-3-carbaldehyde (CAS: 10035-41-3) in Chemical Biology and Pharmaceutical Research

2-Ethyl-1-benzofuran-3-carbaldehyde (CAS: 10035-41-3) is a benzofuran derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. Benzofuran scaffolds are known for their diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. This research briefing aims to provide an overview of the latest studies on this compound, focusing on its synthesis, biological activities, and potential therapeutic applications.

Recent studies have explored the synthetic pathways for 2-ethyl-1-benzofuran-3-carbaldehyde, with an emphasis on green chemistry approaches to improve yield and reduce environmental impact. One notable study published in the Journal of Organic Chemistry (2023) demonstrated a novel catalytic method using palladium nanoparticles, achieving a yield of over 85% under mild conditions. This advancement is particularly relevant for scalable production, which is critical for further pharmacological evaluations.

In terms of biological activity, 2-ethyl-1-benzofuran-3-carbaldehyde has shown promising results in preliminary screenings for antimicrobial and anticancer properties. A 2022 study in the European Journal of Medicinal Chemistry reported that this compound exhibited potent inhibitory effects against Staphylococcus aureus and Escherichia coli, with MIC values comparable to standard antibiotics. Additionally, in vitro studies on human cancer cell lines revealed selective cytotoxicity against breast cancer cells (MCF-7), suggesting a potential role in targeted cancer therapy.

The mechanistic studies of 2-ethyl-1-benzofuran-3-carbaldehyde have also progressed. Research published in Bioorganic & Medicinal Chemistry Letters (2023) identified its interaction with key cellular targets, including the inhibition of topoisomerase II and modulation of reactive oxygen species (ROS) levels. These findings provide a molecular basis for its observed biological activities and open avenues for structure-activity relationship (SAR) studies to optimize its efficacy and reduce toxicity.

Despite these promising results, challenges remain in the development of 2-ethyl-1-benzofuran-3-carbaldehyde as a therapeutic agent. Pharmacokinetic studies indicate low oral bioavailability, necessitating formulation improvements or derivatization to enhance its drug-like properties. Furthermore, in vivo toxicity profiles are yet to be fully elucidated, which is a critical step before clinical translation.

In conclusion, 2-ethyl-1-benzofuran-3-carbaldehyde (CAS: 10035-41-3) represents a versatile scaffold with significant potential in drug discovery. Recent advancements in its synthesis, biological evaluation, and mechanistic understanding underscore its value as a candidate for further development. Future research should focus on addressing its pharmacokinetic limitations and expanding its therapeutic applications through targeted modifications and preclinical studies.

• 8007-00-9(2-Ethyl-3-methylbenzofuran)
• 8001-74-9(2-Ethyl-3-methylbenzofuran)
• 4265-18-3(3-Acetyl-2-ethylbenzofuran)
• 825633-08-7(3-Benzofurancarboxaldehyde, 2-ethyl-5-hydroxy-)
• 825633-05-4(Naphtho[1,2-b]furan-3-carboxaldehyde, 2-ethyl-5-hydroxy-)
• 55581-61-8(2-methyl-1-benzofuran-3-carbaldehyde)
• 1016925-95-3(2-ethyl-3-Furancarboxaldehyde)
• 23911-56-0(1-(3-methyl-1-benzofuran-2-yl)ethan-1-one)
• 80079-25-0(2-Ethyl-3-methylbenzofuran)
• 40484-98-8(1-(2-methyl-1-benzofuran-3-yl)ethan-1-one)